info:eu-repo/semantics/article
A Symmetrical Dirhenium(I) Complex with 4,4’’-Azobis(2,2’-bipyridine) as a Bridging Ligand: Synthesis, Physicochemical Properties and Applications in Detection of Biologically Relevant Thiols and in Chemotherapy for Bone Cancer
Fecha
2020-10Registro en:
Abate, Pedro Oscar; Sottile, Marco; Leon, Ignacio Esteban; Vergara, Monica Mercedes; Katz, Néstor Eduardo; A Symmetrical Dirhenium(I) Complex with 4,4’’-Azobis(2,2’-bipyridine) as a Bridging Ligand: Synthesis, Physicochemical Properties and Applications in Detection of Biologically Relevant Thiols and in Chemotherapy for Bone Cancer; Sociedade Brasileira de Química; Journal of the Brazilian Chemical Society; 31; 11; 10-2020; 2299-2306
0103-5053
1678-4790
CONICET Digital
CONICET
Autor
Abate, Pedro Oscar
Sottile, Marco
Leon, Ignacio Esteban
Vergara, Monica Mercedes
Katz, Néstor Eduardo
Resumen
A new dinuclear complex of formula [{Re(CO)3(py)}2(μ-4,4”-azobpy)](PF6)2, with py = pyridine and 4,4”-azobpy = 4,4”-azobis(2,2’-bipyridine), has been synthesized and characterized by spectroscopic and electrochemical techniques. The symmetrical nature of the dimetallic cation has been confirmed by nuclear magnetic resonance (NMR) measurements. When adding L-cysteine or L-glutathione, large and rapid changes in its UV-Vis absorption spectra were observed, which can be used for detecting both biologically relevant thiols. A promising activity for using this complex as a chemotherapeutic agent for bone cancer was also disclosed. Quantum mechanical calculations supported the experimental data.